Methods: Post-hoc analysis of pooled clinical study data to investigate efficacy and safety of indacaterol compared with placebo and other long-acting bronchodilators

Some studies have recently been published, showing the possibility of augmenting the bronchodilator efficacy in patients with COPD by using the combination of tiotropium with

guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids. Int J Chron

Long-acting bronchodilators are recommended as a first-choice treatment for COPD patients without frequent and/or severe exacerbations, regardless of symptoms, with

With the idea that genetic traits have a role in treatment response, we aimed to build a prediction model for long-acting bronchodilator treatment response, using

This study suggests that, in the management of COPD patients in Taiwan, the vast majority of prescriptions were oral rather than inhaled bronchodilators, and monotherapy of

• 1940’s inh isoprenaline for asthma:non β2 selective • Later development of β2 selective agonist salbutamol

At the end of the study, a significant difference in SGRQ total score (P < 0.05) and in the Impact score (P Z 0.001) was found between the two groups, with a greater

* Database Investigation (DMV, Criminal, Employment, Bankruptcy, Judgements, Liens) * Attorney Services (Accident Reconstruction, Investigative Services, Process Serving) *

The purpose of this study was to clarify the additive efficacy of short-acting β2-agonists (SABA) or muscarinic antagonists (SAMA) on dynamic hyperinflation and exercise tolerance

Fig. 3 Efficacy of long-acting bronchodilators on isotime inspiratory capacity. Error bars represent 95% confidence intervals.. associated with a reduction of dyspnea during

Concurrent medication sub- groups were segmented by patient treatment status at screening and baseline: maintenance-naïve (no COPD medication except short-acting bronchodilators used

Patients completed four questionnaires after recovering from an exacerbation (COPD Assessment Test [CAT], a Clinical COPD Questionnaire [CCQ], COPD Severity Score [COPDSS],

Individual study results for SGRQ total score at 12 weeks and 6 months: difference in change from baseline (CFB) for treatment versus comparator. Individual study results for

The long-acting inhaled bronchodilators available for use in chronic obstructive pulmonary disease (COPD) vary in their pharmacological class (b 2 -adrenergic agonist

Individual study results for SGRQ total score at 12 weeks and 6 months: difference in change from baseline (CFB) for treatment versus comparator.. Individual study results for

The lower medical utilisation costs in the LA-B group were associated with the lower number of ER visits and hospi- talisations because the cost of inhaled long-acting bron-

Find the concatenated transformation matrix and the transformed vertices for rotatation of 90 about the origin followed by reflection through the line. y